Navigation Links
Study Shows Bacterial Contamination Associated With Home-Laundered Surgical Scrubs Is Significantly Greater Than Other Options
Date:1/8/2010

NORCROSS, Ga., Jan. 8 /PRNewswire/ -- A study comparing the aerobic bacterial bioburden associated with surgical scrub attire shows significantly greater contamination among home-laundered attire than scrubs laundered by the healthcare facility, scrubs sent out by the facility to a third-party company for laundering, or single-use/disposable scrubs. In fact, home-laundered scrubs cleaned and ready to wear had as much bacteria present as facility-laundered, third-party laundered and single-use scrubs which had been worn for one day.

Conducted in the spring of 2009, the study was performed by Bioscience Laboratories, Inc., of Bozeman, Mont., and sponsored by Molnlycke Health Care US, LLC. A total of 80 surgical scrub garments, tops and bottoms, prior to use and after use in the operating room for a day, were collected from multiple healthcare facilities across the U.S. They comprised 10 sets of scrubs in each category: single-use; home-laundered; facility-laundered; and third-party laundered.

The study showed no statistically significant difference in bacterial contamination among facility-laundered, third-party laundered or single-use scrubs prior to use ("clean"), but revealed that the bioburden found on home-laundered scrubs prior to use ("clean") was significantly greater than on any of the other garments (facility-laundered, third-party laundered or single-use, non-woven) that had been worn for a day in the operating room.

"According to these results, a healthcare professional beginning his or her shift in home-laundered scrubs would essentially be wearing scrubs with the same quantity of bacteria as the scrubs of a healthcare professional finishing a shift in worn scrubs," said Heather Beitz, BA MEd, Director of Clinical Research for Molnlycke Health Care.

"This study indicates that home-laundering is not as effective as facility- or third-party laundering in decontaminating surgical scrub attire," Beitz explained. "Another option, of course, is single-use surgical attire. In addition to eliminating cross-contamination concerns as indicated in this study, single-use scrubs are durable and designed for daily use in a variety of surgical procedures and acute care needs and can reduce replacement costs," she added.

BARRIER® surgical scrub suits and jackets, manufactured by Molnlycke Health Care, are non-woven, single-use products that provide comfort with the soft feel of cotton. They are available in extended size ranges (S - 4XL), assuring a variety of fits. Departments benefiting from the use of BARRIER non-woven scrubs and jackets are trauma, isolation, ER, NICU (for parents), L&D (for fathers), cath and GI labs, oncology, and radiology/interventional radiology.

About Molnlycke Health Care US, LLC

Molnlycke Health Care US, LLC, consists of two divisions - Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division (formerly Regent Medical Americas, LLC) encompasses the world's leading manufacturer and supplier of powder-free surgical gloves (Biogel® surgical gloves); the number one supplier (by value) of skin cleanser (Hibiclens® and Hibistat® antiseptics); and BARRIER® protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment.

SOURCE Molnlycke Health Care US, LLC


'/>"/>
SOURCE Molnlycke Health Care US, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):